| Structural basis for angiopoietin-1 mediated signaling initiation | |
Heteromer
Q15389; | 23-536 | 99.81 | |
|
| Angiopoietin-2/Tie2 Complex Crystal Structure | |
Heteromer
O15123; | 23-445 | 99.76 | 1×NAG; 2×NAG; 1×CA; 1×NAG; 2×SO4; |
|
| Crystal structure of Tie2-agonistic antibody in complex with human Tie2 Fn2-3 | |
Heteromer
| 541-735 | 100 | 22×EDO; |
|
| Crystal structure of the membrane proximal three fibronectin type III (FNIII) domains of Tie2 (Tie2… | | homo-2-mer | 442-735 | 99.31 | |
|
| Homodimerization of Tie2 Fibronectin-like domains 1-3 in space group C2 | | homo-2-mer | 443-735 | 100.0 | 1×NAG; 1×NAG; 1×NAG; 4×NAG; |
|
| Homodimerization of Tie2 Fibronectin-like domains 2 and 3 in space group P21 | | homo-2-mer | 542-734 | 100.0 | 1×NAG; 1×NAG; 4×NAG; |
|
| Tie2 Ligand-Binding Domain Crystal Structure | | monomer | 23-445 | 99.76 | 1×NAG; 4×NDG; 4×SO4; |
|
| TIE2 KINASE DOMAIN | | monomer | 813-1121 | 100.0 | |
|
| Crystal structure of cytoplasmic kinase domain of Tie2 complexed with inhibitor CEP11207 | | monomer | 814-1121 | 100.0 | 1×0CE; |
|
| CRYSTAL STRUCTURE OF TIE2 IN COMPLEX WITH DECIPERA COMPOUND DP1919 | | monomer | 816-1122 | 100.0 | 2×SO4; 1×919; |
|
| Structure of the Tie2 kinase domain in complex with a thiazolopyrimidine inhibitor | | monomer | 816-1120 | 99.65 | 1×QQ1; |
|
| Synthesis, Structural Analysis, and SAR Studies of Triazine Derivatives as Potent, Selective Tie-2 … | | monomer | 836-1117 | 100.0 | 1×RAJ; |
|
| Selection of fragments for kinase inhibitor design: decoration is key | | monomer | 838-1117 | 99.57 | 1×3WR; |
|
| Evolution of a highly Selective and Potent 2-(Pyridin-2-yl)-1,3,5-triazine Tie-2 Kinase Inhibitor | | monomer | 838-1117 | 100.0 | 1×MR9; |
|
| Synthesis, Structural Analysis, and SAR Studies of Triazine Derivatives as Potent, Selective Tie-2 … | | monomer | 837-1116 | 100.0 | 1×MUH; |
|
| cFMS tyrosine kinase (tie2 KID) in complex with a pyrimidinopyridone inhibitor | | monomer | 917-935 | 88.89 | 3×SO4; 1×IXH; |
|